Related Experiment Videos
Mediastinal restaging: EUS-FNA offers a new perspective
Jouke T Annema1, Maud Veseliç, Michel I M Versteegh
1Department of Pulmonology C3 P, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden University Medical Center, Leiden, The Netherlands. j.t.annema@lumc.nl
Lung Cancer (Amsterdam, Netherlands)
|December 4, 2003
Summary
Transoesophageal endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is an accurate and safe method for mediastinal restaging in non-small cell lung cancer (NSCLC) after chemotherapy. This minimally invasive technique aids in identifying patients who may benefit from surgery.
Area of Science:
- Oncology
- Gastroenterology
- Pulmonology
Background:
- Mediastinal lymph node staging is crucial for non-small cell lung cancer (NSCLC) treatment planning.
- Current restaging methods like CT scans have limited accuracy, while mediastinoscopy is invasive and technically challenging.
- Induction chemotherapy is used to downstage NSCLC, necessitating accurate restaging.
Purpose of the Study:
- To evaluate the diagnostic value and accuracy of transoesophageal endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for mediastinal restaging in NSCLC patients post-induction chemotherapy.
- To compare EUS-FNA with existing restaging modalities.
Main Methods:
- Nineteen NSCLC patients with confirmed N2 disease underwent mediastinal restaging using EUS-FNA after induction chemotherapy.
- Patients had partial response or stable disease on CT scans.
- EUS-FNA was performed in an ambulatory setting, with subsequent surgical resection for patients restaged as N0.
Main Results:
- EUS-FNA demonstrated high diagnostic accuracy (83%) for mediastinal lymph node restaging.
- Specific performance metrics included 100% positive predictive value, 67% negative predictive value, 75% sensitivity, and 100% specificity.
- No complications were reported during the EUS-FNA procedures.
Conclusions:
- EUS-FNA is an accurate, safe, and minimally invasive technique for mediastinal lymph node restaging in NSCLC after induction therapy.
- EUS-FNA can identify downstaged patients who are candidates for surgical resection.
- This technique may play a significant role in optimizing treatment selection for NSCLC patients.